Dow Up 0.11% Nasdaq Up 0.50%

TrovaGene, Inc. (TROV)

-NasdaqCM
5.84 Down 0.17(2.83%) Aug 29, 4:00PM EDT
|After Hours : 5.90 Up 0.06 (1.03%) Aug 29, 5:06PM EDT
Prev Close:6.01
Open:6.03
Bid:5.70 x 2000
Ask:6.31 x 1100
1y Target Est:9.00
Beta:0.09
Next Earnings Date:N/A
Day's Range:5.77 - 7.10
52wk Range:2.97 - 8.87
Volume:1,181,430
Avg Vol (3m):123,185
Market Cap:110.39M
P/E (ttm):N/A
EPS (ttm):-0.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):440.82
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.74
Quarterly EPS Est (Sep-14) :-0.25
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Trovagene, Inc., a development stage molecular diagnostic company, focuses on the development and commercialization of a proprietary urine-based molecular diagnostic technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback